6 Warren Buffett gurus say his latest deal is a winner —and might not be his last as Berkshire Hathaway CEO

Core Insights - Berkshire Hathaway has announced a $9.7 billion cash acquisition of Occidental Petroleum's chemicals business, OxyChem, marking its largest acquisition since 2022 [1][4] - The deal is seen as beneficial for both parties, with Berkshire securing favorable terms and Occidental reducing its debt significantly [2][3][12] Berkshire Hathaway - The acquisition of OxyChem is viewed as a strategic move, as Berkshire has a history of investment in Occidental, having previously provided $10 billion to finance Occidental's acquisition of Anadarko Petroleum in 2019 [2][4] - Berkshire's cash reserves stood at a record $344 billion at the end of June, positioning the company well for this acquisition [4] - Analysts suggest that the purchase price of about eight times OxyChem's trailing 10-year average pre-tax earnings of $1.2 billion is favorable if earnings trends hold [5][11] Occidental Petroleum - Occidental aims to use the proceeds from the sale of OxyChem to reduce its debt by $6.5 billion, targeting a debt level below $15 billion [4][6] - The company has faced challenges with depressed oil prices affecting its chemicals division, projecting OxyChem's profits to fall to a five-year low of $850 million this year [11] - The sale is expected to help Occidental strengthen its balance sheet and potentially resume stock buybacks [6][12] Leadership Transition - Greg Abel is set to succeed Warren Buffett as CEO of Berkshire Hathaway at the end of the year, while Buffett will remain as chairman [13] - The OxyChem acquisition is considered a fitting final deal for Buffett, reflecting his long-term relationship with Occidental [13][14] - Analysts believe that Abel will likely collaborate with Buffett during the transition period, especially in identifying future investment opportunities [14][15]